DERMATA THERAPEUTICS, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2023 - Q4(Jul 23 · Aug 23 · Sep 23)
Total Assets
$8M
↑+122.5% +$4Mvs FY2024
Total Liabilities
$2M
↓-16.8% -$332Kvs FY2024
Equity
$6M
↑+298.7% +$5Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $8M | $4M |
| Current Assets | $0 | $0 |
| Cash | $8M | $3M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $0 | $0 |
| Non-Current Assets | $8M | $4M |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $8M | $4M |
| Total Liab+Eq | $8M | $4M |
| Current Liab. | $0 | $0 |
| Accounts Payable | $461K | $808K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $0 | $0 |
| Non-Current Liab. | $2M | $2M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $2M | $2M |
| Equity | $6M | $2M |
| Retained Earnings | $73M | $66M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · DRMA · Comparing FY2025 vs FY2024